Search

everythinglearnresearchcommunity

for

Search:↓

SLE patients need careful diagnosis to distinguish infections from disease flares for proper treatment.

Early referral to a pediatric rheumatologist and thorough evaluation are crucial for treating complex overlap syndromes effectively.

Accurate diagnosis of SLE requires extensive testing due to its complex symptoms.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.

TB lymphadenitis can occur in people with SLE on long-term immunosuppressive therapy.

A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Lupus can cause hair loss and nail changes, with treatments available for both.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Early recognition and management of connective tissue diseases like lupus are crucial in young patients.

A patient with both bullous lichen planus and systemic lupus erythematosus showed improvement with treatment.

A woman with both TLE and SLE improved with hydroxychloroquine treatment.

Managing multiple autoimmune diseases in one patient is very challenging.

MicroRNAs are important for skin development and diseases and could be used for treatment and diagnosis.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

SLE can cause unusual gastrointestinal symptoms, and immunosuppressive therapy can be effective.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Early diagnosis and aggressive treatment are crucial for managing SLE-related pancreatitis in children.

Early recognition and a multidisciplinary approach are crucial for effectively managing complex autoimmune conditions like SLE with CAPS and AHA.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

Intravenous cyclophosphamide effectively treated steroid-resistant lupus cystitis and peritonitis.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.